| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |